SETD2-SMARCC1 Fusion FISH Probe
The SETD2-SMARCC1 Fusion FISH Probe is used to confirm a fusion of the SETD2 and SMARCC1 genes. The fusion of the SETD2 and SMARCC1 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SETD2-SMARCC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-SMARCC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
SMARCC1 Gene Summary
The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI and contains a predicted leucine zipper motif typical of many transcription factors. [provided by RefSeq, Jul 2008]
Gene Name: SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin Subfamily C Member 1
Chromosome: CHR3: 47627377 -47823405
Locus: 3p21.31
SETD2 Gene Summary
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
Gene Name: SET Domain Containing 2
Chromosome: CHR3: 47057897 -47205467
Locus: 3p21.31
Gene Diseases
The SETD2 SMARCC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|